About Foresite Capital
Foresite Capital is a company based in New York (United States). It operates as a B2B. Foresite Capital has completed 1 acquisition, including Pardes Biosciences.
- Headquarter New York, United States
-
Sectors
Financial Services
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Foresite Capital
Unlock access to complete
Unlock access to complete
Funding Insights of Foresite Capital
Detailed funding history for Foresite Capital
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Foresite Capital
Foresite Capital has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Pardes Biosciences.
Investment portfolio details for Foresite Capital
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutics for pandemic diseases including SARS-CoV-2 are developed.
|
Locked | Locked | 2020 | Locked |
Complete acquisition details for Foresite Capital
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Foresite Capital
Detailed financials for Foresite Capital
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Foresite Capital Comparisons
Peer comparison for Foresite Capital
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Foresite Capital
Detailed competitors of Foresite Capital
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Foresite Capital
Complete news archive for Foresite Capital
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Foresite Capital
Foresite Capital is headquartered in New York, United States. It is registered at New York, New York, United States.
Multi-stage investment firm invests in healthcare and life sciences companies. The firm focuses on funding businesses at all stages, addressing unmet needs. It employs a data science-driven approach, investing in companies that utilize biology and big data to transform healthcare. The firms investment strategy targets opportunities at the intersection of technology and biotechnology, leveraging a technically skilled investment team.
Foresite Capital has made 1 acquisition, including Pardes Biosciences.